Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting in the Setting of Acute Coronary Syndrome

In this manuscript, the authors describe their findings of an extensive literature review of 12 mostly observational, retrospective studies evaluating the use of dual antiplatelet therapy (DAPT) in patients after CABG. They conclude that there is no clear consensus regarding the use DAPT in patients undergoing CABG. Nevertheless, if not contraindicated, it is reasonable to use DAPT following CABG in the setting of acute coronary syndrome, starting in the postoperative period when chest tube drainage is acceptable.